Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
SURVANTA ABBVIE CORPORATION Resolved 25MG Updated Report 2024-05-11 226027
VISIPAQUE 270 GE HEALTHCARE CANADA INC Actual shortage 550MG Updated Report 2024-05-11 227151
MIDAZOLAM INJECTION SANDOZ CANADA INCORPORATED Resolved 5MG Updated Report 2024-05-11 192022
AVENTYL AA PHARMA INC Resolved 10MG Updated Report 2024-05-11 224511
BREVICON 0.5/35 TABLETS (28-DAY PACK) PFIZER CANADA ULC Actual shortage .5MG .035MG Updated Report 2024-05-11 226997
ARTHROTEC 75 PFIZER CANADA ULC Actual shortage 200MCG 75MG Updated Report 2024-05-11 227000
ACH-OLMESARTAN HCTZ ACCORD HEALTHCARE INC Actual shortage 40MG 25MG Updated Report 2024-05-11 227794
APO-FINGOLIMOD APOTEX INC Actual shortage 0.5MG Updated Report 2024-05-10 216744
APO-TICAGRELOR APOTEX INC Actual shortage 90MG Updated Report 2024-05-10 225026
APO-WARFARIN APOTEX INC Actual shortage 1MG Updated Report 2024-05-10 225782
APO-WARFARIN APOTEX INC Actual shortage 1MG Updated Report 2024-05-10 224589
APO-ATORVASTATIN APOTEX INC Actual shortage 80MG Updated Report 2024-05-10 227088
METHOTREXATE SUBCUTANEOUS ACCORD HEALTHCARE INC Resolved 20MG Updated Report 2024-05-10 225687
ACH-SOLIFENACIN SUCCINATE ACCORD HEALTHCARE INC Actual shortage 5MG New Report 2024-05-10 227797
COTAZYM ORGANON CANADA INC. Anticipated shortage 35000UNIT 40000UNIT 10000UNIT Updated Report 2024-05-10 225096
PMS-TENOFOVIR PHARMASCIENCE INC Actual shortage 300MG New Report 2024-05-10 227785
APO-TRIMEBUTINE APOTEX INC Resolved 100MG Updated Report 2024-05-10 225767
APO-OXCARBAZEPINE APOTEX INC Resolved 300MG Updated Report 2024-05-10 224598
APO-OXCARBAZEPINE APOTEX INC Resolved 150MG Updated Report 2024-05-10 219159
PMS-METRONIDAZOLE PHARMASCIENCE INC Actual shortage 500MG New Report 2024-05-10 227776
PMS-GABAPENTIN PHARMASCIENCE INC Actual shortage 400MG Updated Report 2024-05-10 227771
PMS-SUMATRIPTAN PHARMASCIENCE INC Actual shortage 50MG Updated Report 2024-05-10 222384
PMS-VALPROIC ACID E.C. PHARMASCIENCE INC Actual shortage 500MG Updated Report 2024-05-10 153637
PMS-VALACYCLOVIR PHARMASCIENCE INC Actual shortage 500MG Updated Report 2024-05-10 222390
PMS-SALBUTAMOL PHARMASCIENCE INC Resolved 2MG Updated Report 2024-05-10 224605
!!T3 OLESTYR PHARMASCIENCE INC Actual shortage 4G Updated Report 2024-05-10 196455
PMS-MEMANTINE PHARMASCIENCE INC Resolved 5.0MG Updated Report 2024-05-10 214343
PMS-LOSARTAN PHARMASCIENCE INC Actual shortage 25MG Updated Report 2024-05-10 214340
PMS-IPRATROPIUM PHARMASCIENCE INC Actual shortage 21MCG Updated Report 2024-05-10 214337
PMS-ESCITALOPRAM PHARMASCIENCE INC Actual shortage 20MG Updated Report 2024-05-10 204508
PMS-ESCITALOPRAM PHARMASCIENCE INC Actual shortage 20MG Updated Report 2024-05-10 204505
PMS-DICLOFENAC-MISOPROSTOL PHARMASCIENCE INC Actual shortage 200MCG 75MG Updated Report 2024-05-10 222378
PMS-DICLOFENAC-MISOPROSTOL PHARMASCIENCE INC Actual shortage 200MCG 50MG Updated Report 2024-05-10 210336
PMS-DICLOFENAC PHARMASCIENCE INC Actual shortage 50MG Updated Report 2024-05-10 222372
PMS-CIPROFLOXACIN XL PHARMASCIENCE INC Actual shortage 500MG Updated Report 2024-05-10 194525
PMS-AMIODARONE PHARMASCIENCE INC Resolved 200MG Updated Report 2024-05-10 222366
!!T3 APO-COLESEVELAM APOTEX INC Actual shortage 625MG Updated Report 2024-05-10 216646
NAT-ESCITALOPRAM NATCO PHARMA (CANADA) INC Resolved 20MG Updated Report 2024-05-10 218258
APO-DOXY CAP 100MG APOTEX INC Actual shortage 100MG New Report 2024-05-10 227728
APO-ATORVASTATIN APOTEX INC Actual shortage 80MG Updated Report 2024-05-10 227725
APO-ACETAMINOPHEN EXTRA STRENGTH APOTEX INC Actual shortage 500MG New Report 2024-05-10 227722
APO-OLMESARTAN APOTEX INC Actual shortage 20MG Updated Report 2024-05-10 216711
APO-SITAGLIPTIN MALATE APOTEX INC Actual shortage 25MG New Report 2024-05-10 227717
APO-VALACYCLOVIR APOTEX INC Actual shortage 1000MG New Report 2024-05-10 227714
APO-VALACYCLOVIR APOTEX INC Actual shortage 500MG Updated Report 2024-05-10 227031
APO-LEFLUNOMIDE APOTEX INC Actual shortage 20MG Updated Report 2024-05-10 226315
APO-ALFUZOSIN APOTEX INC Actual shortage 10MG Updated Report 2024-05-10 225779
APO-DASATINIB APOTEX INC Actual shortage 70MG Updated Report 2024-05-10 225776
APO-TERBINAFINE APOTEX INC Actual shortage 250MG Updated Report 2024-05-10 225005
APO-AMLODIPINE-ATORVASTATIN APOTEX INC Actual shortage 80MG 10MG Updated Report 2024-05-10 219843

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
MYLAN-NITRO SUBLINGUAL SPRAY MYLAN PHARMACEUTICALS ULC Discontinued 0.4MG New Report 2024-05-08 227338
CHAMPIX PFIZER CANADA ULC Discontinued 1MG 0.5MG New Report 2024-05-03 227052
CHAMPIX PFIZER CANADA ULC Discontinued 1MG New Report 2024-05-03 227049
CHAMPIX PFIZER CANADA ULC Discontinued 0.5MG New Report 2024-05-03 227046
AUBAGIO SANOFI-AVENTIS CANADA INC To be discontinued 14MG New Report 2024-05-02 226847
SANDOZ OXYCODONE/ACETAMINOPHEN SANDOZ CANADA INCORPORATED Discontinued 325MG 5MG Updated Report 2024-05-02 226748
SANDOZ OXYCODONE/ACETAMINOPHEN SANDOZ CANADA INCORPORATED Discontinued 325MG 5MG Updated Report 2024-05-02 226753
HUMULIN R ELI LILLY CANADA INC To be discontinued 100UNIT New Report 2024-05-02 224344
SANDOZ D 10 000 SANDOZ CANADA INCORPORATED Discontinued 10000UNIT Updated Report 2024-05-02 226738
SANDOZ DOCUSATE SODIUM SANDOZ CANADA INCORPORATED Discontinued 100MG Updated Report 2024-05-02 226758